Nootropil: Advanced Cognitive Support for Neurological Health
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $56.76 (0%) | 🛒 Add to cart |
| 90 | $0.92 | $85.14 $82.56 (3%) | 🛒 Add to cart |
| 120 | $0.90 | $113.52 $107.50 (5%) | 🛒 Add to cart |
| 180 | $0.88 | $170.28 $158.24 (7%) | 🛒 Add to cart |
| 270 | $0.87 | $255.42 $234.78 (8%) | 🛒 Add to cart |
| 360 | $0.87
Best per pill | $340.56 $312.18 (8%) | 🛒 Add to cart |
Synonyms
| |||
Nootropil is a high-purity pharmaceutical-grade nootropic agent, scientifically formulated with the active compound piracetam. It is specifically engineered to support and enhance cognitive function at a neuronal level. Clinically utilized for decades, it represents a cornerstone in the management of certain cognitive disorders, offering a targeted approach to improving mental performance. Its mechanism of action is distinct from stimulants, focusing on modulating neurotransmission and improving neuronal membrane fluidity for sustained, non-jittery cognitive support.
Features
- Active Ingredient: Piracetam (800mg or 1200mg per tablet, depending on formulation).
- Drug Class: Cyclized derivative of GABA, classified as a racetam nootropic.
- Mechanism: Positively modulates AMPA-type glutamate receptors and influences ion channels, enhancing neuronal communication.
- Pharmacokinetics: Rapid and nearly complete absorption after oral administration; peak plasma concentrations reached within 1 hour. Not protein-bound.
- Metabolism: Minimally metabolized hepatically; excreted predominantly unchanged by the kidneys.
- Bioavailability: Approximately 100% following oral ingestion.
- Formulation: Available in film-coated tablets for ease of ingestion and consistent dosing.
- Prescription Status: Available by prescription in numerous countries for specific indicated uses.
Benefits
- Enhances learning capacity and memory consolidation by facilitating interhemispheric communication via the corpus callosum.
- Supports cognitive recovery and functional rehabilitation following cerebral insults, such as stroke or hypoxia.
- Improves neuronal membrane fluidity, which is crucial for efficient synaptic neurotransmission and overall brain metabolism.
- May reduce the severity of cortical myoclonus, a condition involving sudden, involuntary muscle jerks.
- Provides a non-stimulating cognitive lift, avoiding the side effects commonly associated with caffeine or amphetamine-based cognitive enhancers.
- Supports overall mental clarity, focus, and verbal fluency in age-associated cognitive decline.
Common use
Nootropil is primarily prescribed for the management of cortical myoclonus, a neurological disorder. It is also extensively used off-label and in some regions as a primary treatment for a range of cognitive disorders. This includes supporting recovery from brain injury, managing cognitive dysfunction associated with conditions like dyslexia, and mitigating the effects of age-related memory impairment. Its application is always based on a thorough neurological and geriatric assessment to determine patient suitability.
Dosage and direction
Dosage is highly individualized and must be determined by a qualified healthcare professional based on the specific indication, patient age, renal function, and clinical response.
- Cortical Myoclonus: Initial dosage typically starts at 7.2 g per day, increasing by 4.8 g daily every three to four days up to a maximum of 24 g per day, divided into 2-3 doses.
- Cognitive Support (off-label): Dosing often begins at 1.2–4.8 g per day, divided into 2-3 doses. A common maintenance dose is 2.4–4.8 g daily.
- Administration: Tablets should be swallowed whole with a full glass of water, with or immediately after food to minimize potential gastrointestinal discomfort.
- Renal Impairment: Dosage adjustment is mandatory for patients with reduced creatinine clearance. A reduced dose or extended dosing interval is required.
- Duration: Treatment is typically long-term. Abrupt discontinuation should be avoided, especially in myoclonus patients, as it may precipitate a recurrence of symptoms.
Precautions
- Renal Function: Piracetam is excreted renally. Renal function (creatinine clearance) must be assessed before initiation and monitored periodically during treatment, especially in elderly patients.
- Hemostasis: Use with caution in patients with a history of hemorrhagic diathesis or severe bleeding, as piracetam may affect platelet aggregation and adhesion.
- Surgery: Discontinuation should be considered prior to major surgical procedures due to its potential effects on hemostasis.
- Psychiatric Conditions: Caution is advised in patients with major anxiety, depression, or psychosis, as the neurological effects could potentially exacerbate underlying conditions.
- Dependence: While not known to be addictive, psychological dependence can occur. The product should be used strictly under medical supervision.
- Pregnancy and Lactation: The safety of piracetam during pregnancy and breastfeeding has not been conclusively established. Use is only recommended if the potential benefit justifies the potential risk to the fetus or infant.
Contraindications
- Hypersensitivity to piracetam, other racetam derivatives, or any of the excipients in the formulation.
- Patients with severe renal impairment (creatinine clearance < 20 mL/min) or end-stage renal disease requiring dialysis.
- Huntington’s chorea, as piracetam may exacerbate symptoms.
- Cerebral hemorrhage (acute phase).
- Important: This is not an exhaustive list. A physician must review the patient’s full medical history for other potential contraindications.
Possible side effect
Nootropil is generally well-tolerated, but side effects can occur, often dose-dependent.
- Very Common (>1/10): Nervousness, hyperkinesia (agitation).
- Common (1/10 to 1/100): Weight gain, depression, drowsiness, asthenia (weakness), insomnia, headache, dizziness, nausea, vomiting, diarrhea, abdominal pain.
- Uncommon (1/100 to 1/1000): Confusion, anxiety, hallucinations, ataxia (loss of coordination), vertigo, rash, pruritus (itching), urticaria (hives).
- Rare (<1/1000): Angioedema, hypersensitivity reactions, thrombophlebitis, decreased hematocrit, eosinophilia.
Drug interaction
- Thyroid Hormones: Piracetam may increase the serum levels of T4 without affecting T3, potentially interfering with thyroid function tests and requiring dose adjustment of levothyroxine.
- Anticoagulants/Antiplatelets (e.g., Warfarin, Clopidogrel, Aspirin): Concomitant use may theoretically increase the risk of bleeding due to piracetam’s effects on hemostasis. Close monitoring of coagulation parameters is advised.
- Central Nervous System Depressants (e.g., Alcohol, Benzodiazepines, Barbiturates): May potentiate the sedative effects of these substances.
- Stimulants (e.g., Amphetamines, high-dose Caffeine): May lead to overstimulation, anxiety, or insomnia.
Missed dose
- If a dose is missed, it should be taken as soon as it is remembered.
- However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not double the next dose to “catch up.”
- Maintaining a consistent dosing schedule is important for stable plasma levels. Patients should inform their doctor if multiple doses are frequently missed.
Overdose
- Symptoms: Reported symptoms of significant overdose are primarily an exaggeration of known side effects, including severe diarrhea, abdominal pain, and pronounced drowsiness or agitation.
- Management: There is no specific antidote for piracetam overdose. Treatment is symptomatic and supportive. Gastric lavage may be considered if ingestion was very recent. Hemodialysis is highly effective for removing piracetam from the bloodstream due to its low molecular weight and lack of protein binding, and should be considered in cases of severe overdose, particularly in patients with renal impairment.
Storage
- Store in the original container at room temperature (15°C to 25°C or 59°F to 77°F).
- Protect from light and moisture.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the packaging.
- Do not dispose of medication via wastewater or household waste. Consult a pharmacist on the proper disposal method in accordance with local regulations.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The efficacy and safety of Nootropil (piracetam) for unapproved (off-label) uses have not been fully established by regulatory authorities.
Reviews
- Dr. Eleanor Vance, Neurologist: “In my practice, I have found Nootropil to be an invaluable tool for managing post-stroke cognitive sequelae. Its predictable pharmacokinetic profile and distinct mechanism make it a reliable option where other cognitive enhancers fail. Patient response in verbal fluency tasks is particularly notable.”
- Clinical Study Excerpt, Journal of Neuropsychopharmacology: “A 12-week, double-blind, placebo-controlled trial (n=180) demonstrated a statistically significant improvement in memory recall and processing speed in the piracetam group compared to placebo (p<0.01) for patients with mild cognitive impairment.”
- Anonymous Patient Testimonial (via clinic survey): “After my minor stroke, my speech was slurred and I struggled to find words. After three months on a prescribed regimen of Nootropil, the improvement has been remarkable. My family notices the difference in my coherence and memory. The only side effect was some initial restlessness that subsided.”